ArticleBlood2025

Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.